130 related articles for article (PubMed ID: 22194994)
1. Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.
Rajan P; Dalgliesh C; Carling PJ; Buist T; Zhang C; Grellscheid SN; Armstrong K; Stockley J; Simillion C; Gaughan L; Kalna G; Zhang MQ; Robson CN; Leung HY; Elliott DJ
PLoS One; 2011; 6(12):e29088. PubMed ID: 22194994
[TBL] [Abstract][Full Text] [Related]
2. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
3. A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.
Munkley J; Rajan P; Lafferty NP; Dalgliesh C; Jackson RM; Robson CN; Leung HY; Elliott DJ
Oncotarget; 2014 Jan; 5(1):131-9. PubMed ID: 24318044
[TBL] [Abstract][Full Text] [Related]
4. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.
Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S
Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890
[TBL] [Abstract][Full Text] [Related]
5. Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells.
Munkley J; Lafferty NP; Kalna G; Robson CN; Leung HY; Rajan P; Elliott DJ
BMC Cancer; 2015 Jan; 15():9. PubMed ID: 25592066
[TBL] [Abstract][Full Text] [Related]
6. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
[TBL] [Abstract][Full Text] [Related]
7. Canonical and Nuclear mTOR Specify Distinct Transcriptional Programs in Androgen-Dependent Prostate Cancer Cells.
Chen Y; Han L; Dufour CR; Alfonso A; Giguère V
Mol Cancer Res; 2024 Feb; 22(2):113-124. PubMed ID: 37889103
[TBL] [Abstract][Full Text] [Related]
8. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.
Hu R; Dunn TA; Wei S; Isharwal S; Veltri RW; Humphreys E; Han M; Partin AW; Vessella RL; Isaacs WB; Bova GS; Luo J
Cancer Res; 2009 Jan; 69(1):16-22. PubMed ID: 19117982
[TBL] [Abstract][Full Text] [Related]
9. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells.
Dai X; Shi X; Luo M; Li P; Gao Y
BMC Cancer; 2023 Dec; 23(1):1241. PubMed ID: 38104097
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional programs activated by exposure of human prostate cancer cells to androgen.
DePrimo SE; Diehn M; Nelson JB; Reiter RE; Matese J; Fero M; Tibshirani R; Brown PO; Brooks JD
Genome Biol; 2002 Jun; 3(7):RESEARCH0032. PubMed ID: 12184806
[TBL] [Abstract][Full Text] [Related]
12. MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.
Ruoff R; Weber H; Wang Y; Huang H; Shapiro E; Fenyö D; Garabedian MJ
Sci Rep; 2023 Oct; 13(1):18227. PubMed ID: 37880276
[TBL] [Abstract][Full Text] [Related]
13. Identification of androgen response-related lncRNAs in prostate cancer.
Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S
Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the small RNA transcriptomes of androgen dependent and independent prostate cancer cell line by deep sequencing.
Xu G; Wu J; Zhou L; Chen B; Sun Z; Zhao F; Tao Z
PLoS One; 2010 Nov; 5(11):e15519. PubMed ID: 21152091
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries.
Romanuik TL; Wang G; Holt RA; Jones SJ; Marra MA; Sadar MD
BMC Genomics; 2009 Oct; 10():476. PubMed ID: 19832994
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.
Munkley J; Vodak D; Livermore KE; James K; Wilson BT; Knight B; Mccullagh P; Mcgrath J; Crundwell M; Harries LW; Leung HY; Robson CN; Mills IG; Rajan P; Elliott DJ
EBioMedicine; 2016 Jun; 8():103-116. PubMed ID: 27428423
[TBL] [Abstract][Full Text] [Related]
17. Genomic analysis of DNA repair genes and androgen signaling in prostate cancer.
Jividen K; Kedzierska KZ; Yang CS; Szlachta K; Ratan A; Paschal BM
BMC Cancer; 2018 Oct; 18(1):960. PubMed ID: 30305041
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells.
Rondeau G; Abedinpour P; Chrastina A; Pelayo J; Borgstrom P; Welsh J
Sci Rep; 2018 Feb; 8(1):2694. PubMed ID: 29426892
[TBL] [Abstract][Full Text] [Related]
19. Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.
Thomas BC; Kay JD; Menon S; Vowler SL; Dawson SN; Bucklow LJ; Luxton HJ; Johnston T; Massie CE; Pugh M; Warren AY; Barker P; Burling K; Lynch AG; George A; Burge J; Corcoran M; Stearn S; Lamb AD; Sharma NL; Shaw GL; Neal DE; Whitaker HC
Endocr Relat Cancer; 2016 Oct; 23(10):797-812. PubMed ID: 27578825
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-coupled expansion of AR activity promotes cancer progression.
McNair C; Urbanucci A; Comstock CE; Augello MA; Goodwin JF; Launchbury R; Zhao SG; Schiewer MJ; Ertel A; Karnes J; Davicioni E; Wang L; Wang Q; Mills IG; Feng FY; Li W; Carroll JS; Knudsen KE
Oncogene; 2017 Mar; 36(12):1655-1668. PubMed ID: 27669432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]